NYSE:CNC - Centene Stock Price, Forecast & News

Centene trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNC."

Shares of Centene split before market open on Wednesday, February 6th 2019. The 2-1 split was announced on Tuesday, February 5th 2019. The newly created shares were payable to shareholders after the market closes on Tuesday, February 5th 2019. An investor that had 100 shares of Centene stock prior to the split would have 200 shares after the split.

Centene Corp (NYSE:CNC) announced its quarterly earnings results on Tuesday, February, 4th. The company reported $0.73 EPS for the quarter, meeting analysts' consensus estimates of $0.73. The firm earned $18.86 billion during the quarter, compared to the consensus estimate of $18.45 billion. Centene had a return on equity of 15.18% and a net margin of 1.77%. The business's revenue for the quarter was up 13.9% compared to the same quarter last year. During the same period last year, the firm earned $0.69 EPS. View Centene's Earnings History.

Centene is scheduled to release their next quarterly earnings announcement on Tuesday, April 28th 2020. View Earnings Estimates for Centene.

Centene updated its FY 2020 Pre-Market earnings guidance on Tuesday, February, 4th. The company provided earnings per share (EPS) guidance of 4.64-4.84 for the period, compared to the Thomson Reuters consensus estimate of $4.80. The company issued revenue guidance of $78.6-79.4 billion, compared to the consensus revenue estimate of $84.49 billion.

17 equities research analysts have issued 12-month price objectives for Centene's stock. Their forecasts range from $60.00 to $103.00. On average, they anticipate Centene's stock price to reach $78.91 in the next twelve months. This suggests a possible upside of 21.5% from the stock's current price. View Analyst Price Targets for Centene.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Centene in the last year. There are currently 2 hold ratings, 14 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Centene.

News coverage about CNC stock has trended somewhat positive this week, according to InfoTrie. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Centene earned a media sentiment score of 1.8 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Centene.

Some companies that are related to Centene include UnitedHealth Group (UNH), Cigna (CI), Anthem (ANTM), Humana (HUM), WellCare Health Plans (WCG), Molina Healthcare (MOH), Magellan Health (MGLN) and Triple-S Management (GTS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Centene investors own include NVIDIA (NVDA), Alibaba Group (BABA), UnitedHealth Group (UNH), Visa (V), Micron Technology (MU), Netflix (NFLX), Boeing (BA), Home Depot (HD), Adobe (ADBE) and CVS Health (CVS).

Centene's stock is owned by many different of retail and institutional investors. Top institutional shareholders include FMR LLC (6.16%), State Street Corp (4.07%), Boston Partners (1.16%), Lyrical Asset Management LP (1.02%), Maverick Capital Ltd. (0.76%) and Bank of New York Mellon Corp (0.75%). Company insiders that own Centene stock include Brandy Burkhalter, Christopher D Bowers, Jeffrey A Schwaneke, Jesse N Hunter, Jessica L Blume, Keith H Williamson, Mark J Brooks, Michael F Neidorff, Robert K Ditmore and Tommy G Thompson. View Institutional Ownership Trends for Centene.

CNC stock was sold by a variety of institutional investors in the last quarter, including Maverick Capital Ltd., Prudential Financial Inc., Renaissance Technologies LLC, Sculptor Capital LP, AQR Capital Management LLC, Alberta Investment Management Corp, Snow Capital Management LP and Mackay Shields LLC. Company insiders that have sold Centene company stock in the last year include Jesse N Hunter, Keith H Williamson, Michael F Neidorff, Robert K Ditmore and Tommy G Thompson. View Insider Buying and Selling for Centene.

CNC stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Lyrical Asset Management LP, Hotchkis & Wiley Capital Management LLC, Thrivent Financial for Lutherans, Partner Fund Management L.P., Bridger Management LLC, Tavio Capital LLC and Victory Capital Management Inc.. View Insider Buying and Selling for Centene.

Shares of CNC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CNC stock can currently be purchased for approximately $64.94.

Centene has a market capitalization of $26.87 billion and generates $74.64 billion in revenue each year. The company earns $1.32 billion in net income (profit) each year or $4.42 on an earnings per share basis. Centene employs 47,300 workers across the globe.View Additional Information About Centene.

The official website for Centene is http://www.centene.com/.

Centene's mailing address is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. The company can be reached via phone at 314-725-4477 or via email at [email protected]